Prostate Cancer News on BioPortfolio

Biomarker for guiding prostate cancer treatment revealed

Backtoback discoveries from Cleveland Clinic demonstrate for the first time how a testosteronerelated genetic abnormality can help predict individual patient responses to specific prostate cancer therapies.The studies published in the October 12...

Researchers reveal biomarker for guiding prostate cancer treatment

Backtoback discoveries demonstrate for the first time how a testosteronerelated genetic abnormality can help predict individual patient responses to specific prostate cancer therapies. The studies suggest that men who inherit this variant would benefit fro...

Merck Calls It Quits On Anacetrapib

Despite the success in the REVEAL outcomes trial for the cholesteryl ester transfer protein CETP inhibitor Merck will not submit...&160;&160;&160;

Urinary Catheters Market by Product Intermittent Foley Condom Type Coated Uncoated Indication Urinary Incontinence Benign Prostate Hyperplasia Bladder Dysfunction Spinal Cord Injury Gender End User Global Forecast to 2022 Report Updated 01092

The urinary catheters market projected to grow at a CAGR of 8.5.The urinary catheters market is expected to reach USD 2.19 billion by 2022 from USD 1.45 billion in 2017 at a CAGR of 8.5 during the forecast period. The growing prevalence of urinary incontin...

Pages